(CNN) – Great baseball player Yogi Berra once said, “It’s to make predictions, especially about the future. “
Yogi Berra knew nothing about Covid-19 (he died five years ago), but his quotes about the progression of a Covid-19 vaccine.
Over the more than six months, pharmaceutical corporations have made predictions about vaccination times opposed to Covid-19 that have proven to be false.
In a recent example, Pfizer said for weeks that he would know until the end of October whether his vaccine is working or yet on Tuesday, on a call from investors, the company’s CEO necessarily tossed it.
While Pfizer and other corporations have made their statements, they have other times been more definitive about their projections.
Scientists say this deserves to be consulted as we get closer to the vaccine: not everything they hear, because testing and making vaccines is notoriously unpredictable.
“Unexpected things happen all the time in vaccine development,” said Dr. Nelson Michael, an army vaccine specialist who has worked on more than 20 clinical vaccine trials. “There are tons of twists and turns and it’s vital to perceive that. “
Although fitness officials have also made forward-looking statements, they have been more indistinct than pharmaceutical companies.
Last week, the director of the National Institutes of Health, Dr. Francis Collins, told the National Press Club that he remained “cautiously optimistic” that the United States has a Covid-19 vaccine authorized until the end of the year, but warned that “it may simply take longer. “
Dr. Paul Offit, a member of the U. S. Food and Drug Administration’s Vaccine Advisory Committee, has been a member of the U. S. Food and Drug Administration’s Vaccine Advisory Committee. U. S. , he said it would be in the interest of pharmaceutical corporations to avoid forecasting their deadlines.
“Companies avoid making predictions because nature is so humiliating,” Offit said.
In September, Ugur Sahin, CEO of BioNTech, who works with Pfizer on his coronavirus vaccine, told CNN that his company’s vaccine was “almost perfect. “
Scientists interviewed for this story shuddered at the idea of describing a vaccine as “almost perfect” when it has not yet been fully studied in large-scale trials. The Pfizerv vaccine, along with 3 others, is still found in Phase 3 clinical trials in the United States, and no one knows if it works at all, that they are almost perfect.
The vaccines from Pfizer and some other pharmaceutical company, Moderna, are a new breed of generation in their Covid-19 vaccines; no vaccine on the market has ever used it.
Offit said that’s just a precaution.
“This virus has less than a year of existence, and has a number of clinical outcomes that we would never have predicted, and now we’re going to counter it with a vaccine that has no advertising experience. How about a little humility here?” said Offit, a member of the FDA’s Associate Advisory Committee on Biological Products and Vaccines.
According to a BioNTech report sent to CNN, Sahin’s comment was based on initial responses from antibodies and T cells and a favorable protection profile observed in the study so far. It also noted that it was mandatory to expect knowledge of effectiveness that was not yet available.
Pfizer’s CEO has made predictions about when a vaccine that is running or not will be transparent.
On September 8, AlbertBourla told today’s exhibit that “we will have an until the end of October” if the vaccine works, adding that “our model, our fundamental case, predicts that we will have a until the end of October. ” this is just a prediction.
On October 16, Bourla made a comment in an open letter on his company’s website, stating that “we will possibly know whether or not our vaccine is effective until the end of October.
But in the investor call on Tuesday, just five days before the end of the month, Bourla said the company had not yet realized its knowledge of vaccines. be in poor health with Covid-19, and Bourla told investors that this had not yet happened.
Reaching those 32 instances of coronavirus will still give the company the knowledge it needs An independent panel of experts will have to analyze those instances, and it can take at least a week, Bourla told investors, meaning knowledge can simply arrive. October, as Bourla predicted.
CNN approached Pfizer for an answer.
“I don’t think our CEO or said the globals deserve to be expecting an announcement by the end of the month. Rather, there was a prospect that we knew of effectiveness until the end of the month. Nothing has changed,” said a corporate spokesman, he said.
Pfizer is the only company that has made predictions that are unlikely to come true or materialize.
In April, Oxford researcher Sarah Gilbert told The Times in the UK that she was “80% convinced” that the vaccine evolved through her team would work, even though Oxford had not even begun its Phase 3 clinical trials at the time.
In May, CNN Oxford researcher Dr. Adrian Hill would finish the university trial.
“I think July would be good. It’s more likely August. Maybe September,” he says. ” We’re aiming for September, but we hope to finish before that. “
September came and went. Even now, the Oxford Phase 3 trial is ongoing.
“We have noticed with this pandemic that spread and transmission rates have fluctuated, making them difficult to predict, and vital measures to control cases, such as blocking through the British government, have slowed the transmission rate,” an Oxford spokesman wrote in an email to CNN. “We have argued that if transmission remains high, we may gain enough knowledge in a few months to see if the vaccine works, but if the degrees of transmission decrease, this procedure may take longer. “
The spread of a virus is unpredictable, and vaccine experts say that’s precisely why pharmaceutical corporations avoid making predictions.
In Phase 3 trials, pharmaceutical corporations vaccinate participants, examine participants, and then check if they are inflamed in their daily lives. As the degrees of virus decrease, fewer participants will become inflamed, slowing down the trial.
Even after clinical trials have ended, production disorders can occur. This is true for many vaccines and this may also be true for Covid-19 vaccines.
“People don’t think about production, but production has killed a lot of products,” said Norman Baylor, former director of the FDA’s vaccine studies office.
Drugs sometimes use chemicals, but vaccines treat living material in development, which does not pass as planned.
“It gets crazier when living systems get involved,” Baylor said. “Making a vaccine is like cooking. One recipe would possibly work well one day but not the next. “
That’s why vaccine experts say the best-designed plans can go a long way.
“The most productive case ever happens,” said Michael, director of the Center for Infectious Disease Research at the Walter Reed Army Research Institute. “Shocks and warts occur in vaccine development.
Or, to quote Berra again, “it’s not over until it’s over. “
The-CNN-Wire ™ and © 2020 Cable News Network, Inc. , a Time Warner company. All rights are reserved.